Mapping the translational science policy ‘valley of death’
Open Access
- 27 July 2013
- journal article
- research article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 2 (1) , 14
Abstract
Translating the knowledge from biomedical science into clinical applications that help patients has been compared to crossing a valley of death because of the many issues that separate the bench from the bedside and threaten to stall progress. But translation is also inhibited by a science policy environment with its own impediments. Mapping these policy impediments give a more complete picture of the valley of death. Stem cell science is one example where success in moving from the bench to the bedside has confronted policy challenges generating difficulties as challenging as those facing scientists and clinicians. We highlight some of the characteristics and challenges of the science policy valley of death common to the U.S. and Europe, illustrate them with a recent example from stem cell science, and describe some promising strategies for traversing the valley.Keywords
Funding Information
- National Center for Research Resources (UL1RR025761)
- Seventh Framework Programme
This publication has 41 references indexed in Scilit:
- A Collaboratively-Derived Science-Policy Research AgendaPLOS ONE, 2012
- Deriving Competencies for Mentors of Clinical and Translational ScholarsClinical and Translational Science, 2012
- State strategies of governance in biomedical innovation: aligning conceptual approaches for understanding 'Rising Powers' in the global contextGlobalization and Health, 2011
- Successfully Accelerating Translational Research at an Academic Medical Center: The University of Michigan‐Coulter Translational Research Partnership ProgramClinical and Translational Science, 2010
- Traversing the Valley of Death: A Guide to Assessing Prospects for Translational SuccessScience Translational Medicine, 2009
- The good, the bad and the ugly red tape of biomedical researchEMBO Reports, 2009
- The Meaning of Translational Research and Why It MattersJAMA, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Deliberative Democracy and the Epistemic Benefits of DiversityEpisteme, 2006
- Embryonic Stem Cell Lines Derived from Human BlastocystsScience, 1998